Changelog Master Feed AI's role in reprogramming immunity (Practical AI #183)
18 snips
Jun 28, 2022 Join Drausin Wulsin, Director of ML at Immunai, as he explores the groundbreaking intersection of AI and immunotherapy. He discusses how AI is revolutionizing treatments for cancer and autoimmune diseases by analyzing vast biological data. Wulsin highlights the innovative immune database AMICA, which leverages advanced machine learning techniques. The conversation also touches on the significance of transfer learning and the collaborative future of AI in drug discovery, promising exciting advancements in therapeutic development.
AI Snips
Chapters
Transcript
Episode notes
Advancements in Genomics
- AI algorithms and experimental techniques in genomics are in a race, each pushing the other forward.
- Experimental techniques, particularly in single-cell profiling, may be advancing even faster than AI algorithms.
Single-Cell Data
- Single-cell data includes measurements of DNA activity, messenger RNA (mRNA), and proteins.
- These measurements offer different perspectives on cell function, with trade-offs in scope, quality, and cost.
The Immune System and Immunotherapy
- The immune system acts like a complex defense force with specialized cells for different threats.
- Immunotherapy 'coaches' the immune system to enhance its cancer-fighting abilities.